Brazil’s Pre-Zika Microcephaly Cases

A review of four years’ worth of medical records finds far greater numbers of microcephaly cases from before the ongoing Zika virus epidemic than had been officially reported.

Written byKerry Grens
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA, NASAIn the past year, clinicians in Brazil have reported around 4,700 babies with suspected microcephaly, and reviews of 400 of the infants have confirmed the birth defect (another 700 suspected instances of microcephaly have been ruled out). The numbers are alarming to many clinicians in the South American nation. Some have questioned whether the cause of this increase in microcephaly is due to Zika virus—a hypothesis favored by many doctors and public health officials—other infections, or simply a catch-up in reporting.

To get a grasp on just how much the prevalence of microcephaly has changed recently, Sandra da Silva Mattos of the Círculo do Coração de Pernambuco and colleagues combed through the medical records of more than 16,000 babies. The infants were born between 2012 and 2015 at one of 21 medical centers in the state of Paraíba, which has been hard hit by Zika.

Since 2012, Mattos’s team found, a strikingly large number of babies—4 percent to 8 percent—appeared to have microcephaly, according to the broadest definitions of the term. Additionally, the number of babies affected peaked in 2014, before Zika had been detected in Brazil.

“What we expected was that we would have something like three to four cases a year of microcephaly—that is ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies